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NEW (3rd) EDITION JUST READY 
Arthritis and Allied Conditions 
By BERNARD I. COMROE, M.D., F. A. C. P. 
Associate in Medicine, University of Pennsylvania; 
Senior Ward Physician and Chief of the Arthritis 
Oinic, Hospital of the University of Pennsylvania 
Large octaYo, 1359 pages, illustrated with 329 engrayings •.. Cloth $12.00 
In the preparation of the third edition of 
this unusually successful work, the text has 
been greatly enlarged. It includes thirteen 
entirely new chapters and more than a hun-
dred new photographs. Practically every 
page has been revised or rewritten in order 
to exclude antedated material and to include 
every new and important development in 
this field. In its present form the book is 
nearly twice as large as the previous edition. 
The new chapters cover such topics as 
penicillin psychogenic factors in rheumatic 
diseases, rheumatic manifestations of tropi-
cal diseases, common mistakes in the 
diagnosis of arthritis and allied conditions. 
The diagnostic and therapeutic features 
have been written primarily for the general 
practitioner and enable him personally to 
diagnose and care for thq great majority of 
his patients who suffer trom these condit-
ions. 
LEA & FEBIGER 
600 Washington Square Philadelphia 6, Pa. 
Acute Medical Disorders 
DIAGNOSIS AND TREATMENT 
THE acute episodes of disease and the emergencies which at times attain life endangering importance must be regarded as among the most disturbing prob-
lems that confront the practitioner of medicine. When a physician is faced 
with some acute episode in the course of a disease, he needs precise information 
in a concise and readily accessible form. 
Few men are so well qualified to write such a book as is Dr. Murphy-who 
has sought to make this book essentially practical. This volume is the only text 
with which· we are familiar that meets these requirements and makes it possible 
for the hard-pressed doctor to obtain urgently needed help without searching 
numerous comprehensive medical texts. 
By: Francis D. Murphy, M. D., F. A. C. P., Professor and Head of 
the Department of Medicine, Marquette University School of Med-
icine; Clinical Director of the Milwaukee County General Hospital 
and Emergency Unit. 
)10 Pages Illustrated $6.00 
F. A. DAVIS COMPANY 1914- 16 CHERRY ST. 
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NEW DEVELOPMENT IN ANTISYPHILITIC THERAPY 
EDWIN H. CRESSMAN 
Professo~ of Der1natology and Syphilology 
Introduction 
\IV ill syphilis succumb to the onslaught of modern medicine? Through 
the years this disease has pursued its insidious, stubborn way, devastating 
the minds and bodies of' its poor victims. T ts swath of devastation has 
dwarfed the greatest of epidemics and wor · conflicts. Its destruction is 
rwt sporadic but continues from month to month and year to year without 
abatement. The day will come when this dread disease will suffer the fate 
of many another great plague, such as smallpox and diphtheria, but it 
will not be as easy. In controlling communicable disease we think of quick, 
sure diagnosis, segregation until the danger is over, a rapid and certain 
cure, and that which has been most successful, artificial immunization. 
Historical Summary 
Up to the present time we have only had the quick, sure diagnosis. 
The serologic tests have given us this. Their success or failure is in direct 
proportion to the frequency of their use. They can find syphilis, but what 
then? Can the patient be segregated until the danger is over? Segregation 
is impossible except for a small group. Can the; disease be rapidly and 
certainly cured? Perhaps. This hope has been existent since Ehrlich's dis-
covery of arsphenamine in 1909. Artificial immunization is usually the 
most successful method of attack on communicable disease, but there is 
little hope of this for syphilis. Unfortunately syphilis is primarily a vener-
eal disease, which complicates the problem in manifold ways. 
To understand the trend of new research in the treatment of syphilis 
a brief recapitulation is worthwhile. In 1909 when Ehrlich synthesized 
arsphenamine he performed a chemical miracle. Highly poisonous arsenic 
had a high affinity for body cells, and a low affinity for the spirochete of 
syphilis. Ehrlich succeeded in reversing this effect. His new compound, 
arsphenamine, was strongly parasitotropic, and only weakly organotropic. 
Doses large enough to kill the organism could be introduced into the blood 
without great danger to the patient. Ehrlich believed he had discovered 
the "therapia sterihsans magna". The effects of the new drug were spec-
tacular. Chancres and eruptions rapidly disappeared, usually after a single 
injection. This was indeed a medical triumph over the ineffectual mercury 
therapy of previous years. But it was not long before it was realized that 
very few of these patients were completely cured. There were numerous 
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symptomatic relapses, and many cases of late syphilis developed. Then 
the treatment plan was intensified, taking a trend somewhat similar to 
some of the modern plans of intensification. Daily injections of arsphena-
mine were used for three successive days in the intensified plan of Pol-
litzer which was much in vogue. This was often repeated after a period of 
6 to 8 weeks of mercury. Others gave daily injections of arsphenamine for 
4, 5 or 6 days, etc. There were many plans. Arsphenamine in these plans 
of intensive dosage were found to be too dangerous, and the percentage 
of cures was not high enough, although the immediate clinical results in 
early syphilis were spectacular. 
Later, Stokes,! writing in 1926, made this comment: "A modern critic 
of such schemes of treatment* must, of course, point out that from the 
standpoint of curative effect, the wearing out of the infection is often 
possible where the effort to crush it at the start may fail." Gradually there 
evolved longer plans and more conservative dosage. In view of the earlier 
work, it is interesting to note that in 1944 we read of 332 cases of early 
syphilis treated with old arsphenamine given daily for 5 to 6 days. 2 In this 
work the conclusion was reached that the plan was ineffective, dangerous, 
expensive, and altogether impractical. It would seem that this was dis-
covered more than 20 years before by others. 
In evaluating any new syphilotherapy the following questions must 
be considered: ( 1) Is it more effective? ( 2) Is it less dangerous? ( 3) Is 
it less expensive? ( 4) Is it simplified (easier for the patient, or easier 
for the physician) ? ( 5) In addition to these criteria, it must further be 
remembered that the success of any plan can be determined only after 
many years of observing treated patients. 
For some years the treatment of syphilis has followed a conservative 
plan in most cases. In early syphilis about 1 Y2 years of this form of treat-
ment was needed. In some forms of late syphilis a much longer period is 
required. In these plans treatment danger has been reduced, and in early 
syphilis the rate of cure has been high. The results in late syphilis have 
been reasonably good, considering the fact that many of these advanced 
forms are irreversible pathologies. 
In 1933 Leifer, Chargin, and Hyman 3 initiated a vast amount of in-
vestigation. Once started, research ga·ined tremendous momentum. 0~1ce 
again there has been a revival of the sea_rch for some plan approachmg 
the "therapia sterilisans magna" of Ehrhch-a modern massive arseno-
therapy. New drugs were tried-neoarsphenamine, mapharsen and others. 
Neoarsphenamine in intensive dosage was found to be more dangerous than 
mapharsen, and was discarded in favor of the latter. 
New methods of administration were tried. It was thought that the 
intravenous drip method would reduce the drug danger of massive ~ose 
therapy. This is doubted now, and it is p~obable that the mo~e convement 
syringe technique is not mor~ dangerous If the same dosage 'LS used. 
*Intensified plans using daily injections of arsphenamine. 
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Fever therapy combined with the various drugs was tried, hoping 
that it would reduce th~· drug danger, or increase the curability, or do 
both. In these intensive plans fever was used daily, and at various other 
intervals. Fever seemed to add something to the effectiveness of treat-
ment, and while it did not diminish the toxicity of the arsphenamines if 
the same dosage was used, as good results could be obtained with smaller 
doses of the drua, and so the danger was reduced. Fever was induced in 
various ways, by
0 
malaria, by cabinet, by blanket, and by typhoid vaccine. 
The simplest plan is by the injection of typhoid vaccine. 
Various durations of intensive therapy were tried, varying from 1 to 
20 days. As might be expected the drug danger was greatly increased, 
particularly the more serious, and sometimes fatal, reactions _of encephal-
opathy and agranulocytosis. While the search for a short, qmck ~ure con-
tinued, investigation also took another direction. Drugs were gtven less 
often than in the intensive plans, and for longer periods of time-30 days, 
8 weeks, 12 weeks, 26 weeks, thus constituting semi-intensive plans of 
therapy. Perhaps in the final analysis none of thes: plans of massive .a.r-
senotherapy will be permanently adopted as a routme for . ea_rly syphths. 
Yet even if this proves to be the case, a great deal of credtt ts due those 
men who aroused the renewed interest in a search for shorter and better 
methods of syphilotherapy. 
Perti11e11t Research Findings in Intensive Therapy 
From the literature on intensive therapy much can be gleaned which 
is valuable not only for the intensive plans for early syphilis, but also for 
the management of syphilis treated under conservative plans, an~ in other 
stages. The following is a brief summary of some of the more 'important 
facts. 
M apharsen Prefe1'1'ed 
The arsphenamine of choice in any of the intensified plans of therapy 
now in use is mapharsen.3 The difference in toxicity between neoarsphena-
mine and mapharsen when used in the weekly injection method of conserv~­
tive treatment is only very slightly in favor of mapharsen. But the tox_1c 
ratio changes greatly in favor of mapharsen when the drugs are used m 
intensive and semi-intensive plans. At the present time no other arsphena-
mine should be used for this purpose. 
Dosage of M apharsen 
The dosage of mapharsen 4· 5• 9• 10• 13• under any plan of trea~ment 
should be governed by the weight of the patient, and not ~y ~n. arbttrary 
dosage according to sex, as was customary practice. The md1v1d':tal dose 
hould not exceed 1 mgm. per kgm. of body weight in any intenstve pl~~ 
of treatment. In all plans for the treatment of early syphilis the approxi-
mate individual dose should be based on these figures. 
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In the therapy of early syphilis the greater the size of the individual 
dose the greater the therapeutic effectiveness. Contrary to what one might 
believe, the interval between doses in massive therapy is not so important. 
Much more important is the total amount given throughout the entire 
treatment period. It seems quite evident that the total amount given has 
a direct relation to the therapeutic effectiveness. The total curative dose for 
intensive and semi-intensive plans of therapy is from 20 to 30 mgm. per 
kgm. of body weight, giving total dosages of from 1200 to 1500 mgm. 
The total curative dose for the weekly conservative plan of treatment 
should be somewhat higher, from 30 mgm. to 40 mgm. per kgm. of body 
weight, or a total dosage of from 1600 to 2400 mgm. 
Efficacy of Intensive Therapy 
Intensification does not increase the therapeutic efficacy.n It now 
seems apparent that the conservative plan of weekly injections offers as 
high a ratio of cures as can be atta:ined by any intensive or semi-intensive 
plan. When the various systems are properly managed, comparable re-
sults are obtained. 
Risk of Intensive Therapy 
Intensification of therapy increases the drug risk .in direct proportion 
to the degree of intensification!, 5· 6· 9• 10• In other words, the shorter the 
treatment period the greater the drug danger, if the treatment plan is to 
produce comparable results. It seems highly likely that at the present time 
there is no plan completed in less than 20 days which gives a sufficient 
margin of safety. 
lid ethods of Administration 
The methods used for administering the drug 6 have been slow in-
travenous drip, rapid intravenou drip, and multiple injections by syringe. 
In the beginning it was believed that the slow intravenous method would 
permit the administration of large closes repeated daily without great 
drug danger. This does not seem to be the case with arsenical drugs in 
the treatment of syphilis. Drug reaction is in proportion to the size of the 
dose, and the frequency of administration. In other words, if the same 
dose is given and repeated at the same time interval, there is no difference 
in the number of toxic reactions whether it be administered by slow drip, 
rapid drip, or by syringe. Since the syringe method is simpler, it should 
now be the method of choice. 
Antidote for Arsphenam1"ne 
If massive close therapy is ever to become routine it must be made 
safer. For many years there has been a search for an antidote which 
might be combined with the arsphenamine drugs in the treatment of 
NEW DEVELOPME TTS IN ANTISYPHILITIC THERAPY 5 
syphilis. Such an antidote, if found, might. be administered coincidentally 
and would make it possible to administer larger doses with greater safety. 
At present nothing which has been tried has proven effective in reducing 
the toxicity of these ckugs. 
Dosage in Sccolldary Syphilis 
In order to obtain the same rate of cure secondary syphilis reqmres 
larger arsenical dosage than does primary syphilis.4• 9 
Serologic Tests in Intensive Therapy 
In a review of quantitative serologic studies in the treatment of early 
syphilis by the intensive plans of therapy some interesting and perhaps 
valuable, information can be obtained. 7· 9• 11• 13 The serologic tests remain 
positive for a variable length of time after intensive therapy. During this 
time the serologic titre is gradually falling. In general, the earlier a pa-
tient starts treatment the sooner the serun1 becomes negative. Patients with 
a lower titre at the beginning of treatment have better results than those 
with a higher titre. It has been suggested that patients may be treated by 
greater or lesser total dosage of arsenicals depending upon the character 
of the titre response. At the present time titre estimation is not part of 
the routine treatment of syphilis, hut is under study by many clinics. It 
may be possible that titre estimation before and during treatment may be 
of value in judging the progress of the case. 
Gnder any of the intensive or semi-intensive plans of treatment the 
patient should be examined, and a blood , erologic test should be clone 
monthly for 6 months, and repeated in the ninth and twelfth month after 
the completion of treatment. The pinal fluid should he examined during 
the period between the sixth and the t\vel fth months after completion of 
treatment. After this the patient should have the conventional bi-annual 
oh~eryation for a period of 5 years. 
Combined Dr11g TlzC'rapy 
It has been demonstrated that the combined use of arsphenamines and 
bismuth given at one and the same time has an additive and synergistic 
effect. !!· 15 The spirillicidal and curative effects of the tvvo drugs when used 
at the same time are greater than when either of the drugs is used individ-
ually. Furthermore, this does not increase the drug danger. If desired 
the drug danger in combined arsphenamine-bismuth treatment can actually 
he reduced by reducing the dose of the arsenical without sacrificing thera-
peutic efficacy. This plan of combined drug therapy is not new. It is par-
ticularly applicable in the treatment of early syphilis. It should be used in 
all plans, \\·hether intensive. semi-intensive· or conservative. 
Co/llbi11ed Drug and Fe7!Cr TlzNapy 
Since there appears to be a synergism, or an increased therapeutic 
effect, when fever is combined with drugs in intensive therapy/· 12• 14 it 
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effect. !!· 15 The spirillicidal and curative effects of the tvvo drugs when used 
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he reduced by reducing the dose of the arsenical without sacrificing thera-
peutic efficacy. This plan of combined drug therapy is not new. It is par-
ticularly applicable in the treatment of early syphilis. It should be used in 
all plans, \\·hether intensive. semi-intensive· or conservative. 
Co/llbi11ed Drug and Fe7!Cr TlzNapy 
Since there appears to be a synergism, or an increased therapeutic 
effect, when fever is combined with drugs in intensive therapy/· 12• 14 it 
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seems logical that the danger of this therapy can be lessened by reducing 
the dosage of mapharsen, and combining it with some form of fever ther-
apy. The trend at present seems to favor 2 or 3 prolonged, high fevers, 
in the cause of treatment. 
Conservative Therapy for Early Syphilis 
The conservative plan of therapy in which weekly doses of arsphena-
mine and bismuth are administered for a period of approximately 10 
years has not been replaced by any of the intensive or semi-intensive plans. 
With the conservative plan of therapy there is less drug risk. A 5-day 
treatment plan, for instance, has a drug risk approximately 100 to 200 
times greater. Other plans of therapy carry a drug risk in direct propor-
tion to the length of the period of treatment. It is also evident that the 
conservative plan of therapy, if properly managed, has a cure rate as 
good or better than any of the massive do e plans yet introduced. 
M a.pharsen Preferred 
While mapharsen is the drug of choice at the present time, it should 
be noted that the difference between neoarsphenamine and mapharsen in 
reaction incidence, when used in the weekly injection plan, is very slight. 
The two drugs can be used interchangeably, with a slight preference for 
maphar.sen. If reactions occur with one drug a change can be made to the 
other, and at times the reactions will be avoided. Newer drugs, such as 
phenarsine hydrochloride and chlorarsen, may prove to be equally effective, 
but are too recent for accurate evaluation. 
Dosage of Mapharsen 
The older method of dosage according to sex (0.04 gm. for the female 
and 0.06 gm. of mapharsen for the male) should be discarded. The single 
weekly dose should approximate 1 mgm. per kgm. of body weight. The 
following dosage of mapharsen is suggested for both male and female: 
Under 110 pounds ...................... 0.04 gm. 
110 to 135 pounds ............... 0.04 or 0.05 gm. 
Above 135 pounds ...................... 0.06 gm. 
In using other arsenicals, dosage according to weight should also be em-
ployed. 
Combined Drug Therapy 
Bismuth is used in conjunction with mapharsen. Subsalicylate of bis-
muth suspended in oil is the preparation of choice because it pennits the 
injection of a single weekly dose. Other preparations which are more 
rapidly absorbed must be injected more often. A standard preparation 
contains 0.13 gm. or 2 grains per cc. The following dosage of bismuth 
subsalicylate is recommended: 
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"Cnder 135 pounds . . . . . . . . . . . . . . . . 1.0 cc. (2 gr.) 
135 to 150 pounds .............. 1.25 cc. (20 gr.) 
Ov~. 150 pound . . ....... . ........ 1.5 cc. (3 gr.) 
There is not the slightest doubt that great therapeutic advantage in the 
treatment of early syphilis is gained by using arsphenamine and bismuth 
as a combined therapy for 12 to 16 weeks at the beginning of treatment. 
Doses of each are given each week. The first 3 to -+ months are most im-
portant. H.egularity of treatment is of utmost importance during this per-
iod if relapse, and neurosyphilis are to be prevented. The following is an 
outline of a plan we use : 
12 ":'eeks of mapharsen. 
Give bismuth subsalicyJate the first -+ weeks, omit the next 
4 weeks and give again during the last 4 weeks of this period. 
4 weeks of bismuth alone. 
10 weeks of mapharsen. 
Give bismuth the first 2 weeks and the last 2 weeks of this 
period. 
6 weeks of bismuth. 
10 weeks of mapharsen. 
8 weeks of bismuth. 
6 weeks of mapharsen. 
14 weeks of bismuth. 
Treatment is given for 70 weeks as outlined above, providing the blood 
serology becomes - negative during the first 6 to 9 months and remains 
negative, and providing the spinal fluid examination is completely normal. 
Longer treatment plans are necessary in cases with persistant positive ser-
ology, serologic relapse, or nervous system invasion. 
Serologic Tests During Conse1'vative Therapj! 
The blood serology should be repeated every 3 or 4 months. Do not 
omit this because the blood becomes negative, serologic relapse can occur. 
The spinal fluid is examined any time after one year, but before completion 
of therapy. (Cell count, mastic or gold sol., globulin estimation, and the 
Kolmer complement fixation test are done.) After completion of treatment 
the blood serology should be watched for 2 or 3 years for possible relapse. 
Indications and Plans for Intensive Therapy in Early Syphilis 
Since the drug danger has not been reduced to a point where it com-
pares with the safety of more conservative plans, and since no increased 
therapeutic effectiveness has been demonstrated for any reasonably safe 
plan, intensive therapy cannot be recommended for those who can and will 
pursue one of the longer, more conservative plans. But since early syphilis 
1s a communicable disease all uncooperative patients should be hospitalized 
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and treated by intensive methods. This should be accomplished by com-
pulsion through the state health departments if it is to be successful. 
Ten-Day Plan 
Gnder these circumstances a plan of treatment covering 10 davs as 
de ·cribed by Thomas and Wexler,1x is one of the best. Daily injectio;1s of 
mapharsen by syringe are combined with bismuth, and fever is produced 
by the simple device of injecting typhoid vaccine. The daily dose of 
mapharsen for most patients is 0.06 gm. but the single doses should not 
exceed 1 mgm. per kgm. of body weight. Bismuth ·ubsalicylate in do e-
of 0.1 gm. is injected on the fiLt, third, seventh, and tenth days. Fevers 
are induced on the second, fourth, sixth, and eighth clays by the intraven-
ous injection of typhoid-paratyphoid vaccine. The initial injection i 0.1 
cc .. the second injection is 0.2 cc., the third 0.-t cc., and the fourth 0.6 cc. 
In order to induce the desired rise in temperature, it is usually nece .ary 
to repeat each close in from 10 to 2 hours. However, the dosage on each 
fever day is gauged by the febrile reaction produced. The amounts of vac-
cine suggested vvill usually cause a fever of 104° for about 4 hours. 
Eight to Twebe-vV cek Plan 
There are occasional circumstances which may make it desirable for 
·ome patients to choose some intensi,·e plan of therapy. Under these con-
ditions the patient should be advised of the increased risk before treat-
ment. Hospitalization for one of the highly intensified plans is not de.;;ir-
able for this patient. vVith le s risk, less expense, without bouts of high 
fever, and with the patient remaining ambulant, a moderately inten ifiecl 
plan of treatment can be completed in 8 to 12 weeks. 1\Iapharsen i- in-
jected 3 times weekly until a total of 1500 mgm. is reached. The individual 
doses vary from 0.0-t gm. to 0.06 gm. according to weight as stated pre\·i-
ously. Once weekly an injection of 2 to 3 grains of bismuth subsalicylate 
is given. starting \vith the first injection of mapharsen. 
Tzventy-Six ~V eek Plan 
In July 1942 the U. S .. \rmy adopted a plan of treatment which 1s 
consummated in 26 \veeks.w In this plan mapharsen is given twice \Yeekly 
for 10 weeks, it is stopped for 6 weeks, then given again twice weekly for 
10 weeks. Bismuth is injected once weekly during the first 5 weeks, then 
stopped for 5 weeks, then given alone for 6 weeks, stopped for 5 weeks, 
and given again during the last 5 weeks. With this plan effective therapy 
can be given with only slightly greater risk than in the conventional plan. 
The only patients who should he selected for this plan of treatment are 
those who, because of some circumstances, would probably not he able to 
complete a conservative routine. 
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Risk in Relation to Intensity of Therapy 
As is indicated in the above data the risk becomes less as the plan of 
therapy is _ ngthenecl. In general, then, the indications for, or the choice 
of, a plan of therapy can be liberalized in direct proportion to the length 
of the plan, providing, of course, it offers equal therapeutic effectiveness. 
Fever Therapy 
In addition to the use of fever therapy in the treatment of early 
syphilis already discussed, fever treatment is useful in the treatment of 
·ome forms of neurosyphilis, ocular syphilis, and probably in sero-resistant 
latent syphilis. Various forms of fever are in use today: malarial therapy, 
intravenous typhoid vaccine, and physical fever produced by the blanket 
method or by the cabinet method. The results of recent work 8 would 
indicate that malarial therapy has no therapeutic advantage over fever 
artificially produced, and that in the treatment of syphilis, the results are 
definitely inferior if low temperature levels are employed. Temperature 
levels higher than 104° are necessary. The duration of the fever is also 
important. Longer periods of fever are more effective. This is particularly 
important in the treatment of neurosyphilis. Therapeutic effectiveness is 
probably increased when fev-er therapy and drug therapy are used con-
currently. 
Rapzd Treatment of Neurosyphilis 
Recently Dattner, Thomas, and Wexler 17 have discussed a plan for 
the rapid treatment of neurosyphilis. Patients under this plan were hos-
pitalized for malarial th<;rapy. After the termination of the malaria, 10 
daily injections of mapharsen were administered while the patient re-
mained in the hospital. In a control group, patients were given malarial 
therapy followed by routine (prolonged) chemotherapy. Various forms 
of neuro yphilis were treated. In tabulating the results of these 2 plans 
of therapy, it vvas demonstrated that results obtained by the rapid method 
were as satisfactory as the results obtained with prolonged therapy. 
The results of this plan proved again the effectiveness of fever ther-
apy in the various forms of neurosyphilis. But more important, they 
indicate the possibility of an effective rapid form of therapy. A longer 
period of observation is necessary to judge the permanenc~ of the results 
which were obtained. 
Penicillin in tlze Treatment of Syphilis 
Arsenotherapy was a tremendous stride in the control and treatment 
of syphilis. But in spite of their great effectiveness, the arsphenamines, 
both new and old, are dangerous drugs. l\Ia .. ny have died, and many have 
suffered from drug reactions such as nausea and v-omiting, dermatitis, 
hepatitis. encephalitis, etc., to ay nothing of the excruciating pain, and 
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perhaps slough, caused by extravasation of the drug outside the vein. 
Bismuth was a comparatively harmless drug and added much to syphilo-
therapy, but it did not have the punch necessary to cure a high percentage 
of cases of early syphilis. It was milder in action, and could only be used 
when combined with the arsphenamines, or in the treatment of pathologies 
which required mild therapy such as advanced cardio-vascular syphilis. 
The next important advance in the chemotherapy of infectious diseases 
was the discovery of the sulfa group. These drugs, however, proved in-
effectual against the spirochete of syphilis. Now an antibacterial of most 
remarkable character, penicillin, virtually harmless to the human organism, 
and yet more potent in its peculiar way than the sulfa drugs, has been 
discovered. Could this drug have any value in the treatment of syphilis? 
Em:ly l11vestigations 
John F. Mahoney 18 of the U. S. Public Health Service, and Director 
of the Venereal Disease Research Laboratory at the U. S. Marine Hospital, 
Staten Island, N. Y., was destined to find out. He suspended the spiro-
chetes of syphilis in a solution of penicillin and observed the result under 
the dark field microscope. One can imagine his emotions, realizing what 
this could mean, when he observed that penicillin had no effect whatever. 
The organisms were vigorously motile right in a concentrated solution of 
the drug. Here the investigation might have ended. To go further seemed 
useless. Nevertheless, animal experimentation was done, and strange as it 
may seem, spirochetocidal activity was demonstrated. This would seem 
paradoxical. It is certainly unexplainable. 
The next step was to determine its usefulness in the treatment of 
human syphilis. Four cases of primary syphilis were selected for the first 
experiment. Each had a penile lesion with a positive dark field, and posi-
tive serology. Within the first 8 hours after penicillin therapy was begun 
the patients developed mild Herxheimer effects. The symptoms were head-
ache, malaise, mild rise in fever, the penile lesions became painful, and the 
regional lymph glands became enlarged and tender. One patient had a 
mild secondary syphilid. These are reactions which occur the first clay of 
the treatment with the arsphenamines, and are indicative of a marked 
effect of the drug upon the disease, probably spirillicidal. Furthermore, the 
spirochetes had clisappe~red from the penile lesions within 16 hours. The 
positive serology became negative in the usual length of time. Later Ma-
honey and his associates 19 reported on a series of 100 cases of early 
syphilis treated with penicillin. There were some failures in this group, 
indicating the need for further study of time-dosage factors. 
In the meantime a group of 23 cooperating clinics had been appointed 
by the Subcommittee on Venereal Diseases of the National Research 
Council to study penicillin in the treatment of syphilis, and to pool the 
results in an effort to determine the optimum method of using the drug. 
The preliminary report, 20 on 1418 cases of early syphilis under treatment 
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by this group describes the various dosage systems used, and the trial of 
penicillin CO' 1bined with mapharsen. At the same time the action of peni-
cillin on lak syphilis is also being studied by this same group. From 
these and various other reports 18• 19• 20• 21• 22• 23• 24• 25 the following conclusions 
might be reached regarding the present status of penicillin in syphilis. It 
must be remembered that all of the reports are preliminary, the amount of 
work done is small, and as yet the period of observation is short. 
Penicillin Dosage 
The optimum time and dosage relationship of penicillin in the treat-
ment of any form of syphilis has not yet been established. 
It appears that the minimum dose in early syphilis should be 1,200,000 
units, and probably should be higher. This amount is administered in an 
8-day period. An individual dose of 20,000 units is repeated every 3 hours. 
It is probable that the most effective treatment of early syphilis may 
prove to be a combination of penicillin and mapharsen. 
Nothing can yet be said about the dosage in late syphilis. 
Since therapeutic shock (Herxheimer reaction) occurs, this danger 
must be guarded against in some forms of late syphilis by the use of smaller 
preliminary dosage, as in the use of other highly spirillicidal drugs. 
It is possible that smaller doses for longer periods may be more ef-
fective in neurosyphilis. 
Large dosage must be avoided for the first 48 hours in the treatment 
of syphilis of pregnancy because of the tendency to produce abortion. The 
individual doses for about 2 days should be about 10,000 units, after which 
higher doses can be given. 
No dosage has yet been established for the treatment of infants. 
Total dosages now being used vary from 16,000 to 19,000 units per pound 
of body weight. This is divided and given every 4 hours for 8 days. 
Penicillin Prophylaxis in Syphilis 
Since syphilis and gonorrhea can occur as dual infections, and since 
the incubation period of gonorrhea is shorter than that of syphilis, the use 
of penicillin in the treatment of gonorrhea may introduce confusion in the 
management of cases in which the two infections co-exist. This is so 
because the dosage of 100,000 to 150,000 units of penicillin administered 
in the treatment of gonorrhea does not prevent the development of syphilis, 
though it does seem to lengthen its incubation period to 52 days or longer. 
Penicillin Therapy in Early Syphilis 
Penicillin has an immediate and profound effect in early syphilis. The 
organism rapidly disappears from the lesions, the lesions heal quickly, 
and there is a trend toward serologic reversal. Since, in addition to these 
effects, there is a tendency for the infection to relapse, further study is 
needed to determine the best plan of treatment. 
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by this group describes the various dosage systems used, and the trial of 
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Nothing can yet be said about the dosage in late syphilis. 
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must be guarded against in some forms of late syphilis by the use of smaller 
preliminary dosage, as in the use of other highly spirillicidal drugs. 
It is possible that smaller doses for longer periods may be more ef-
fective in neurosyphilis. 
Large dosage must be avoided for the first 48 hours in the treatment 
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individual doses for about 2 days should be about 10,000 units, after which 
higher doses can be given. 
No dosage has yet been established for the treatment of infants. 
Total dosages now being used vary from 16,000 to 19,000 units per pound 
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Penicillin Prophylaxis in Syphilis 
Since syphilis and gonorrhea can occur as dual infections, and since 
the incubation period of gonorrhea is shorter than that of syphilis, the use 
of penicillin in the treatment of gonorrhea may introduce confusion in the 
management of cases in which the two infections co-exist. This is so 
because the dosage of 100,000 to 150,000 units of penicillin administered 
in the treatment of gonorrhea does not prevent the development of syphilis, 
though it does seem to lengthen its incubation period to 52 days or longer. 
Penicillin Therapy in Early Syphilis 
Penicillin has an immediate and profound effect in early syphilis. The 
organism rapidly disappears from the lesions, the lesions heal quickly, 
and there is a trend toward serologic reversal. Since, in addition to these 
effects, there is a tendency for the infection to relapse, further study is 
needed to determine the best plan of treatment. 
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Herxheimer reactions occur but are not serious in early syphilis. 
If penicillin is used alone, very large dosage is necessary. At the 
present time some of the best results have been obtained by combining a 
small dosage of penicillin with a subcurative dosage of mapharsen. This 
indicates synergism of the two drugs. 
Penicillin Therapy in Syphilis of Pregna11cy and ·in Congenital Syphilis 
The number of cases treated in this category is very scant, but the 
following observations can be made: 
The drug has the ability to cure or to suppress syphilis in pregnancy. 
Miscarriage, stillbirth, and neonatal death has been prevented, and 
the infants have been healthy. 
The larger doses of penicillin produced threatened abortion during 
the first 2 clays of treatment. When the drug was discontinued the symp-
toms subsided, and did not recur when it was resumed 24 hours later. Be-
cause of this tendency it is advised that 0 the usual close be used during 
the first 48 hours. 
Grossly infected infants can be harmed by the injudicious use of pen-
icillin, as with other antisyphilitic drugs. The treatment should be used 
with extreme caution. The dosage should be reduced, and proper general 
pediatric care should be emphasized. 
Penicillin Therapy ·i11 Late Syphilis 
The Penicillin Panel of the National Research Council is studying 
the effect of penicillin therapy in various types of late syphilis. Some few 
preliminary remarks can be made after scanning the literature. 
Gummatous lesions of the skin and bones will heal rapidly with a 
dosage of 300,000 units. 
Psoriasiform cutaneous syphilis which had fa:iled to respond to arsen-
ical and bismuth therapy was cured. 
In neurosyphilis various degrees of symptomatic response have been 
obtained in paresis, tabes dorsalis, meningovascular neurosyphilis, and pri-
mary optic atrophy. 
Some effectiveness is indicated in interstitial keratitis, optic neuritis, 
and iritis. 
Smaller doses seem to have a good effect, particularly in neurosyphilis. 
The effect probably being due to a stimulation of the patient's . natural 
defensive mechanisms. 
Herxheimer effects can be serious, and must be carefully avoided. 
In all types of late syphilis penicillin had a tendency to reduce the 
reagin titre in the blood. This effect was observed in 50 per cent to 60 
per cent of cases. Only 5 seroresistant cases have been treated. One be-
came negative. 
. In neurosyphilis the abnormal spinal fluid improved in varying degrees 
but not in any spectacular fashion in the short period of observation. 
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Conclusions 
In c~.., elusion it seems safe to observe that the treatment of early 
syphilis is about to undergo a revolutionary change. The therapeutic 
action of penicillin parallels that of the arsphenamines, and is remarkably 
free from injurious 'effects. Late syphilis will continue to be a problem 
s·ince many of its pathologies are irreversible, but it seems that this new 
drug will eventually take an important place in its management. 
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The lowly "afterbirth" that down through the ages has been buried 
and destroyed, may contain within itself many secrets. The purpose of this 
paper is to direct more attention to an important organ, an organ with a 
short but vital life. 
During recent years, the diagnosis of placenta praevia by roentgen-
ography has become more dependable, clue to the utilization of the Snow 
and Powell technique, and variations of it. These procedures enable one 
to visualize the soft tissues of advanced pregnancy. It has been observed 
by radiologists that many films made during this period have shown areas 
of altered density at the placental site. This has given rise to the as~ump­
tion that these areas might indicate the presence of infarcts. It was this 
observation and this assumption which prompted this study of the pro-
duction and effects of placental infarcts. Their presence, and possible 
effects, have been the subjects of much discussion, but few, if any, con-
clusions have been reached. 
Apparently the small, white infarcts which appear to some extent 
in practically all placentas, are merely the result of a senile degeneration 
of an organ which at term has performed very important functions, but 
whose life cycle is at an end. These infarcts are small, fibrotic or calcare-
ous deposits which feel sandy on palpation. They are distributed gener-
ally throughout the placental tissue, with a preponderance on the maternal 
surface. Microscopically, they may appear as circumscribed areas which 
have undergone complete necrosis, or the entire mass may have been 
changed into fibrin. Sometimes there are evidences of obliterating en-
darteritis and periarteritis. Certainly we must look upon this type of in-
farct as being within the limits of normality. 
The type of infarct which concerns us most is the large red, or young 
infarct. These are rather pyramidal in shape, extending deeply into the 
placental substance. When present, it is not uncommon to find them in-
volving an entire cotyledon, or group of cotyledons. In fact, they may be 
so extensive as to interfere greatly with foetal nutrition, causing the death 
of the foetus. In patients suffering a severe nephritis, stillbirths probably 
result from this mechanism, because it is this type of patient who often 
exhibits such infarctions. It would appear that daily injections of glucose. 
as well as of progestin and estrogens, might save some of these babies 
carried by mothers suffering from nephritic conditions. This treatment 
seems logical because it is known that glucose can be transmitted through 
the placental mechanism to assist in foetal nutrition. It also may be as-
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sumed that a failing placental organ will be a poor producer of progestin 
and estrogen, two substances necessary to normal gestation. The manner 
in which these large, red infarcts are produced has been a much debated 
subject, but by piecing together known facts, the following mode of pro-
duction may be postulated. 
Blood fibrinogen levels during pregnancy are increased, ranging from 
0.3 - 0.7 gm. per cent. An even greater increase is noted in eclampsia 
where the range may be between 0.36 and 0.95 gm. per cent. As the blood 
fibrinogen level rises, the clotting time decreases, facilitating fibrin forma-
tion in the intervillous spaces where the circulation is sluggish. This sug-
gests a possible reason for the presence of large, red infarcts in the pla-
centas of eclamptic and pre-eclamptic mothers. 
Thus far, the only result of infarction as described, has been an oc-
casional stillbirth when the chorionic destruction has been extensive. But 
there are many other physiochemical changes occurring in the maternal 
organism, and perhaps in the foetus as well, which should be given further 
consideration. vVhen there is tissue destruction, with autolysis present, 
certain split protein compounds are liberated which may affect greatly 
the course of pregnancy and the puerperium. As the. chorionic villi are 
being destroyed, histamine, guanidine, and tissue fibrinogen ( thrombo-
plastin, cephalin) are deposited in the intervillous spaces. These sub-
stances are toxic, and may cause altered physiology, both locally and gen-
erally. 
Once infarction is inaugurated, a vicious cycle is probably set up, and 
further destruction is encouraged by the production of these · substances. 
The increased amount of tissue fibrinogen by still further shortening the 
clotting time, and the histamine by increasing capillary permeability, both 
add to the destructive factors present. 
Histamine is an amine derived from histidine, an amino acid, by re-
moval of the carboxyl group. 
CH = N / COOH CH = N 
I C - CH2 - CH --7 I C - CH2 - CH2 - NH2 + C02 
NH - CH/ "'-NHz NH - CH/ 
HISTIDINE HISTAMINE 
Histamine is a constituent of ergot, and is also known as ergomine. It is 
an oxytoxic substance used experimentally by many physiologists to stim-
ulate uterine contractions. Where infarction invades the maternal surface 
of the placenta, the histamine liberated may tend to set up uterine con-
traction, as well as increase capillary permeability locally, and result in 
the dissection of a portion of the placenta from its uterine attachment. 
This theory seems plausible because placental infarctions are quite com-
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Fig. 1. So 'called infarct of the placenta. A-Normal villi surrounded 
by blood. B-Longitudinally cut villus undergoing necrosis. In the center 
of the illustration, an intervillous fibrinous thrombus enclosing villus B and 
two other necrotic villi cut transversely. Epithelium lost where villi border 
on the thrombus (medium power). From Kaufmann's Pathology, Vol. III, 
Reimann; Blakiston, 1929, p. 1728. 
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monly associated with abruptio placenta. It is fair to assume, however, 
that histamine liberation would probably have no such local effect if the 
infarcts Ee within the substance of the placenta, not adjacent to the inter-
villous spaces. 
Guanidine, an antaognist of calcium, may possibly he derived from 
creatin. 
NH2 - C - N - CH2 - COOH 
/' I 
NH CH3 
CREATIN GUANIDINE 
Guanidine production in the area of infarction may have widespread 
toxic effects. Many experimenters have tried to associate it directly with 
the production of eclampsia. Sublethal closes of guanidine injected into 
cl?gs will produce muscular twitchings similar to the convulsions of eclamp-
Sia, as well as hepatic lesions almost identical with those found in the 
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Reimann; Blakiston, 1929, p. 1728. 
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eclamptic liver. This substance also produces a rise in blood pressure, 
even when present in minute quantities. Blood guanidine levels are mark-
edly increased in the eclamptic mother, ranging from 0.22 to 0.40 mgm. 
per cent. 
Fig. 2. Multiple thrombi, so called white infarcts of the placenta. From 
Kaufmann's Pathology, Vol. III, Reimann; Blakiston, 1929, p. 1728. 
Fig. 3. Placenta showing multiple young red infarcts 
of the maternal surface. Taken from a case of abruptio 
placenta. White areas indicate infarction. Osteopathic 
Hospital of Philadelphia, 1945. 
Errata 
Legends under figures 2 and 3 should be reversed. 
INFARCTION OF THE PLACENTA 19 
This paper has postulated a sequence of pathophysiologic events which 
it is thought may expla·in the production and effects of infarcts in the 
placenta. The need for greater knowledge concerning the normal and 
pathologic physiology of this short lived but important organ is obvious. 
vVe wish to acknowledge the assistance rendered by Drs. ,Lloyd and 
Wheeler, of our radiology department, and by Dr. Olwen Forbes. 
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LYlVIPHATIC LEUKE:MIA: A CASE REPORT WITH 
AUTOPSY FINDI IGS 
WILLIAM BALDWIN, JR. 
Professor of Physiology 
The report of thi~ ca:e falls naturally into four periods of manao·e-
~1ent-the ~rst and thir.d .m the outpatient clinic, the second and fou~th 
m the hospital. The chmcal report will be presented in this order f 1-
lowed by the autopsy report, and discussion of the clinical and radi~logoic 
aspects of the case. 
First Clinic Period 
J A whit~ male, Jewish, ag~ 66, was first seen in the outpatient clinic 
on. a.nuary ~· 1944. The chief complaint at the time of admission was 
pam '111 t 1e nght shoulder and inferior angle of the scapula. The ain ~ad be~1 prese~t for about three years and the patient had been tre~ted 
mf ~~ot ~r hos~Ital for neuralgia and arthritis. The treatment consisted 
o 111Jectwns, diathermy, and sedation. 
H~story. and physical examination revealed the following: 
G_astromtestznal: Negative, except for intolerance to fatty foods and occa-
SIOnal clay colored stools. 
Genitou1-i11ary: Frequency N 0-2 
D - 8-9 no burning, dribbling, etc. 
Cardiovascular: Negative except for dyspnea on exertion. 
Respiratory: Positive for postnasal drip and a history of "fl " fi k 
· d · · . u ve wee s 
pnor to a mJsswn, for which the patient had not received medical attention. 
FmdT~ily dh.istorjl: Negative for carcinoma, diabetes, tuberculosis in anity 
car Iac 1sease and renal disease. ' ' 
Past perso11al ~1istory: Posi~ive for measles, hemorrhoidectomy in 1929, 
appendectomy 111 1935, tons1lectomy in 1937 At the f f d · · 
there · f J B · Ime o a mtsswn 
I . was~ pos_I Ive. . : Murphy sign, prostatic enlargement, an umbilical 
1e~m~i anh a ngh~ mgum~l hernia. There were no palpable lymph nodes 
an a ot er physical findmgs were within normal limits. 
Laboratory findings: 
L.:rinalysis: Essentially negative. 
Blood count: Hemoglobin 71 per cent erythrocytes -+ 360 000 1 59 150 1 1 98 ' ' , , eucocytes , , ymp 1ocytes per cent (57,967), monocytes 2 per cent (1183) 
A rec~eck of the white count on January 24, 1944 showed 76,700 leucocyte~ 
of ~htch 96 per cent (73,632) were lymphocytes and 4 per cent ( 3068) 
wet e polymorphonuclear granulocytes. 
LYMPHATIC LEUKEMIA 21 
A diagnosis was made of lymphatic leukemia, and, after consultation 
with the Department of Radiology, x-ray therapy was instituted April 13, 
1944 and continued until April 27, 194-+ as described in the latter part 
of this paper. 
During this course of therapy there was a progressive decrease in both 
the erythrocyte and leucocyte count as indicated in figure 1 and table 1. 
During this time the patient received regular manipulative therapy for 
his admitting complaint, which condition improved greatly. On April 2, 
1944 liYer. iron, and high vitamin therapy was instituted in an attempt to 
combat the anemia which had appeared. 
On :May 5, 1944 the patient received 500 cc. of whole blood. At this 
time he had three groups of vesicles on an erythematous base in the left 
mandibular and anterior lateral cervical regions. These were thought to 
be herpetic lesions as there was no evidence of cutaneous leukemic infiltra-
tion. The eruptions coalesced forming one large area covering the inferior 
portion of the mandible and the lateral and anterior cervical regions, with 
extension into the clavicular area. The patient meanwhile had become 
Yery weak, and on May 5, 194-+ was confined to bed with a recurring sharp 
rise in afternoon temperature. The liver and spleen were palpable, there 
was a roughening of breath sounds in both lungs, with diminished breath 
sounds, and dullness in the middle and lower lobes of the left lung. 
First Hospital Period 
The patient was hospitalized on May 27, 19-+4. On admission radio-
graphic survey of the chest and abdomen were made and the following 
report ~ubmitted by the radiologist. 
"The chest and abdomen were examined radiographically employing 
survey films as requested. 
"A single anteroposterior film was secured of the chest with the 
patient supine on a hospital litter. This film, while somewhat over-
exposed, shows no frank or pronounced evidence of active lung pathol-
ogy. One might question the localized area of altered density in the 
base of the right lung just lateral to and at the level of the cupola of 
the diaphragm. In the base of the left lung one also notices some 
increased radio density about the basal bronchovascular reticulum, 
and 1t is quite likely that the changes noted on the right side are of 
the same nature and character. There is no massive consolidation 
of lung structure noted, and in the main the pulmonary fields appear 
negative for any change which might be interpreted on the basis of 
metastatic malignancy or leukemoid invasion of the lung fields. The 
extreme supraclavicular portion of the right apex shows diminished 
ventilation. This, however, might be due to pleural thickening and 
probably is the result of such a change, since this finding was also 
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noted at examination of the chest in February of this year. 'The 
mediastinum appears to be rather prominent as to width and this 
might be accounted for on the basis of the patient's position at the 
time of examination. The right mediastinal relief is rather straight, 
quite discrete, somewhat prominent. On the left side the mediastinal 
contour is altered by virtue of fibrosclerotic aortic arch. 
"The abdominal survey film shO\vs a rather marked disturbance in 
soft parts relief clue to gas in the intestines and colon. The liver 
appears to be definitely enlarged. The .spleen is not demonstrated 
in terms of an enlarged organ. Approximating the diaphragmatic 
level and extending below into the upper left quadr-ant of the abdo-
men, a rounded opacity approximating perhaps the size of a large 
orange, was noted. The exact identity of this soft parts shadow 
could not be determined. There was no displacement of the gas 
filled colon in the region of the spleen. The kidneys were not at 
all well demonstrated due to gas 1n the bowel and intestine. The 
lumbar column showed .scoliosis to the left with rather marked spon-
dylotic spurring in the bodies of the lumbar vertebrae which also 
appear to be somewhat narrowed on the concave sid.e of the scoliosis. 
"IMPRESSION: The bronchovascular peribronchial changes noted 
in the basilar portions of both lungs might be the result of lymphatic 
change in the peribronchial lymphatics secondary to leukemic state. 
They might also result from inflammatory reaction of non-specific 
form and be entirely independent of any variation secondary to or 
directly due to a blood dyscrasia. 
"Mediastinal adenopathy and ·widening cannot be established. 
"The liver appears to be definitely enlarged. Splenic enlargement 
cannot be established. The lumbar spine shows evidence of chronic 
spondylosis." 
Table 2 and figure 1 show the clinical progress and therapeutic 
measures taken 1n the management of the blood dyscrasia. Transftisions 
as indicated were given to control the severe anemia present on admission. 
An attempt was made to stimulate granulocytopoiesis by the intramuscular 
injection of 10 cc. of Pentnucleotides three times a day, and the admin-
istration of 4 "yellow bone marrow Glanules'' by mouth 3 times a day. 
This therapy was discontinued at the end of one week because it was felt 
that there was little indication in the blood picture of even minimal 
therapeutic response. 
Sternal puncture under sodium pentothal anesthesia was performed 
on June 8, 1944 and the report on the specimens submitted to the labora-
tory was as follows: 
LYMPHATIC LEUKEMIA 23 
"J\tiACROSCOPY: the specimen submitted was a small portion of 
sternum, measuring 0.7 x 0.4 x 0.4 em. This bone was excessively 
dense and required a great deal of chemical action for decalcification. 
"NIICROSCOPY: Sections of the bone marrow submitted were not 
very satisfactory for examination because there was too much com-
pact bone with little marrow. Also decalcification had to be carried 
out too energetically to yield good materials. These sections give 
the impression of increased density of the compact bone and also 
of the spongy bone. Considerable infiltration by fat is evident, which 
might well be part of the process of senility. Certain portions are 
highly cellular with an impression of crowding out of hemopoietic 
elements. We would be pleased to examine further specimens of 
bone." 
In consultation with the department of radiology it was decided 
to attempt stimulation of bone marrow function with small doses of x-ray 
directed to the ends of the long bones. This therap)1 was instituted on 
June 15, 1944 and continued during the patient's stay in the hospital, and 
continued after his discharge to the outpatient department. 
Because of the low platelet count the possibility of hemorrhagic diathe-
sis was considered, and the stool was examined on June 1, 1944 for blood, 
but the test was negative. The basal metabolic rate determined on June 
2, 1944 was plus 16 per cent. · 
In addition to _.the management of the blood dyscrasia, the cutaneous 
lesion in the region of the left mandibular, and anterior cervical regions 
received attention. This presented a difficult problem because of the 
small number of granulocytes in the blood stream. The lesion was a 
large confluent area of suppuration covered by a very heavy crust. Along 
the margins could be seen superficial, necrotic, suppurative lesions sur-
rounded by erythema and hemorrhage. Because of the crust the bulk 
of the lesion could not be visualized, and hence it was impossible to deter-
mine whether sinuses existed. There was no evidence of leukemic infil-
tration, although the surrounding cervical lymphatics were enlarged. In 
spite of the absence of sensory symptoms this was thought to be a post-
herpetic necrotizing pyodermia. 
After consultation with the department of dermatology cultures of 
the lesion were made. They revealed the presence of staphylococcus-
aureus in a non-hemolytic flora. Smears studied revealed the presence 
of epithelium, pus cells, many staphylococci, and many diptheroids. Blood 
cultures were negative. 
Treatment of the lesion consisted of warm boric acid compresses 
applied for one hour three times a day, and a lifting off of the crusts as 
they become loose. T'his therapy was continued from May 31, 1944 to 
June 6, 1944 at which time the crusts had been removed. Alkaroid pow-
der was applied for one day, and then the lesion was washed with boric 
acid solution. Thereafter daily dressings of 2.5 per cent sulfathiazole 
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oi~tment in va~1ishing c~eam base were applied after washing with boric 
acid. At the time of discharge the lesion had healed completely. 
. Duri~g his .stay .in the l:ospital the patient received soft tissue manip-
u~atwn twice daily with speetal attention directed to the dorsal and splanch-
mc areas. After the temperature had stabilized he was allowed to be 
ambulatory. '!'he general clinical condition gradually improved although 
he was snffenng. from edema of both lower extremities, especially the 
right. He was d1scharged to the outpatient department on J nly 12. 1944. 
Second Clinic Period 
On outpatient service the x-ray therapy was continued. Weekly 
blood counts were made, the results of which are shown in table 3. On 
July 28, 1944 palpable lymph nodes were demonstrated in the left infra-
clavicular region, and left axilla. On July 21, 1944 the patient complained 
of rectal p.ain and. consultation with the department of proctology revealed 
the followmg findmgs: An external hypertrophic skin tab on the left side 
and an external thrombotic hemorrhoid one-half inch in diameter on th~ 
same .side. ~l:e sphincteric tone was. normal. There was a general hyper-
~roph~c proctitis. The mucous membrane was characterized by easy bleed-
mg w1thou.t any break or ulceration. Because of the general physical status 
of the pat1ent treatment was withheld. 
Throughout the t.ime the patient was on outpatient service the pretibial 
and ankle edema pers1stecl. On August 8, 1944 a hard mass was observed 
on the posteromedial side of the right leg midway between the ankle and 
k~1ee. This gaye the patient some pain, and he received x-ray therapy 
d1rected to tl:e mass. On August 14, 1944 the patient complained of 
weakness wh1ch became progressively worse in spite of transfusions of 
500 cc. of whole blood on August 11 and August 25, 1944. 
Second 1-lospital Per£od 
He 'vas readmitted to the hospital September 11, 19-l-4. The blood 
picture changes, daily temperature, and treatment are summarized in table 
4 and figure 3. At this time the erythrocytic sedimentation was as indicated 
in figure 4. 
The general management during this period of hospitalization was 
along the same lines as that during his first hospitalization already dis-
cussed. The mass ·on the right leg presented an additional problem of 
management. It was treated with x-ray and on September 15, 1944 ap-
peared to contain fluid. The skin covering the mass was thin and cyanotic, 
and the lesion was surrounded by a painful, indurated area. The fluid 
was aspirated and about 25 cc. of clear, straw colored fluid was obtained. 
Smears of this fluid revealed pus cells but no microorganisms. Following 
aspiration of lesion refilled rapidly, and on September 19, 1944 it was 
incised, and a small rubber drain inserted. The leg was elevated and hot 
boric acid compresses applied. The wound continued to drain large quan-
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tities of fluid similar to the aspirated sample. On October 6, 1944 cultures 
of the lesion reveale'd the presence of staphlococci and occasional spore 
bearing bacilli in a partially hemolytic flora . 
On October 2, 1944 because of complaints of rectal pain proctologic 
consultation revealed that beneath the skin tab previously reported on the 
left ide there was an oval punched out ulcer with undermined edges 
,vhich bled ea ily and was very sensitive. This was treated with instilla-
tion of cabasil concentrate followed by filling with cabasil surgical powder. 
rrhe patient improved under the care outlined until October 1, 1944 
after which he failed rapidly. He became bedfast on October 6, 1944, 
became incontinent, mentally confused, and irrational, and expired October 
14, 1944. 
Autop:5y No. 44-356 
Died10-1-1---l--l-; 1 P.M. 
Autopsy 10-1-1--44; 4 P.l\11. 
External Examination 
Autopsy Protocol 
The body was that of a small, elderly white male, said to be 66 years 
of age. The hair was thin, and gray-black. Parietal baldness was present. 
A bmw elevation was seen in the left frontal area. The pupils were equal 
in siz; . Upper and lower plates were present. No petechiae were seen 
in the mouth. 
A ·car was seen in the left anterior cervical triangle. The supra-
clavicular glands were enlarged. The chest was barrel shaped. An inci-
sional scar 2 em. in length wa seen over the manubrium sterni. 
Petechiae were noted over the right shoulder and right costal arch. 
Needle wounds and small hematomata , .. ·ere noted in the antecubital fossae. 
The axillary nodes were palpable. 
An incisional scar was seen in the right lower quadrant. There was 
an indirect inguinal· hernia on the right. A turbid discharge was exuding 
from the urethra. The inguinal nodes were palpable. 
Over the outer surface of the right calf was a discolored, ulcerating 
area 12 x 6 em. A central drain was in place. The right foot and ankle 
were edematous. The left was edematous to a lesser degree. Petechiae 
were evident over both tibias. 
Internal Examination 
The subcutaneous fat was 1 em. thick over the abdomen. The peri-
cardia! sac contained 75 cc. of slightly cloudy straw colored fluid. The 
heart measured 13 x 8 x 6 em. in situ, and weighed 270 gms. The cardio-
thoracic ratio was 13/22. The mitral curtain was sclerosed, and evidenced 
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much calcification. The apices of the papillary muscles were scarred. 
Other valves demonstrated no lesions. No emboli were found in the 
pulmonary arteries. The aorta was atherosclerotic throughout, but calcifi-
cation and ulceration were not present. 
Each pleural cavity contained less than 25 c.c. of fluid. The right 
lung was adherent at the apex and to the diaphragm posteriorly. It 
weighed 435 gms. A Chon lesion was demonstrated in the upper border 
of the middle lobe. The lung was edematous, but the bronchi were clear. 
The left lung weighed 670 gms. The bronchi were filled with froth. 
About a third of the upper lobe was involved with an interstitial hemor-
rhage. The remainder was edematous. 
The esophagus was not noteworthy. The rugae of the gastric mucosa 
were flattened, and the membrane contained petechiae. A loop of the 
jejunum was adherent to the oecum, and the scar in the abdominal wall. 
The appendix was absent. The colon presented no abnormalities. 
The liver weighed 2500 gms. The surface was flecked by numerous 
small purplish areas. A hemangioma, 2 em. in size was noted. Bile was 
expressed with ease from the gallbladder. The mucosa of the bladder 
was ribbed and in the lumen was a cholesterol stone 2 em. in diameter. 
The pancreas seemed slightly firmer than usual. The spleen measured 
18 x 13 x 6.5 em. and weighed 530 gms. Follicular hyperplasia was 
marked. The suprarenals had undergone autolysis of the medullary sub-
stance. The mesenteric and retroperitoneal nodes were enlarged and 
firm. 
The kidneys were adherent to the perinephritic fat. They measured and 
weighed respectively right and left 11.5 x 6 x 4.5 em., 10 x 5.5 x 4 em. 
and 140 gms., 110 gms. Small cortical cysts were present. The capsules 
stripped with difficulty. The cortical surfaces were granular. The cut 
surfaces were pale. 
The urinary bladder contained about 5 c.c. of purulent material. The 
mucosa was congested. 
The marrow of the lumbar vertebrae appeared rather normal in the 
gross. That of the sternum was decidedly pale, and the ribs showed 
complete loss of · marrow. 
Gross Anat01nical Diagnosis: 
Nephritis-Third stage 
Chronic Valvular Disease (mitral) 
Myomalacia 
Pulmonary Hemorrhage (interstitial) 
Splenomegalia (leukemic) 
Lymphadenopathy (leukemic) 
Atherosclerosis 
Cholelithiasis 
LYMPHATIC LEUKEMIA 
Cause of Death: 
Chronic Lymphatic Leukemia 
Contributory-
Interstitial Pulmonary Hemorrhage 
Myomalacia 
1V1 icroscopy 
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ections of the lungs demonstrate thickened interalveolar septae. The 
capillaries are congested. In the alveolae is . s~en the pro~ein of ede~a 
fluid. Large numbers of macrophages contammg blood p1gment are m 
the alveolae. Large numbers of small round cells are seen scattered 
through the tissue. They are most numerous about the ve.ssels. Many 
alveolae contain erythrocytes, and in some areas these are m such large 
numbers as almost to obscure the architecture of the lung. 
Sections of the liver show the sinusoids filled with blood. Many of 
the hepatic cells contain blood pigment. The structures of the portal canals 
are almost obscured by round cell infiltration. These round cells are also 
noted in the sinusoids. 
In one area the typical structure of a cavernous hemangioma is seen. 
The supporting stroma of this area is heavily infiltrated with small round 
cells. 
Capillary congestion is seen m sections of the pancreas. 
In the spleen, the malpighian corpuscles are not present. The whole 
tissue is infiltrated by small round cells. 
The lymph nodes show a- loss of normal architecture with replace-
ment by small round cells. The picture is one of monotonous uniformity. 
Sections of a mesenteric lipoma demonstrate an infiltration by the 
same small round cells characteristic of all these sections. 
In the kidney, cloudy swelling is noted. l\1any tubules contain cast . 
All vessels are congested. Here and there collections of the small round 
cells mentioned so often above are noted. 
Sections of the bone marrow demonstrate almost complete replace-
ment by cells of the lymphoblastic series, and fat cells. A few plasma 
cells are noted. The. erythroblastic and myeloblastic series are almost 
nonexistent in these sections. 
Discussio11 
Clinical ~-'"lspects 
:-\!though in many respects the above charts and tables pre ent typical 
characteristics of lymphatic leukemia, neYertheless several interestmg que -
tions arose during the management of this case which merit discussion. 
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T he occupational history of the patient is perhaps worthy of a few 
moments thought. He worked fo r years as a carpenter, hence was prob-
ably in contact with resinous woods, a fact which raises once more the 
question of the carcenogenic properties of these agents. T he attack of 
so-called '' fl u," an acute infection, five weeks prior to the original admis-
sion, fi ts one of the theories proposed of excit ing factors in the on et of 
leukemia. 
TABLE 1 
Erythro- Hemoglobin Lympho- Granulo-Date cytes in Leucocytes Treatment 
millions per cent cytes cytes 
Jan. 17 4.36 71.9 59,150 57,962 1183 
Jan. 24 76,700 73,632 3068 
Mch . 29 4.06 88.20 9,000 8,540 540 X 
Apr. 7 3.65 71.83 8,000 7,600 400 XL 
12 3.25 78.40 6,400 6,144 256 XL 
19 2.80 58.80 6,500 6,175 325 XL 
26 2.35 58.80 10,000 9,600 400 L 
l\1ay 1 2.60 52.30 7,750 7,507 310 L 
5 2.30 55.60 8,550 8,380 170 L 
10 2.35 52.00 8,700 8,178 522 L 
23 2.40 -19.00 17,500 17,325 175 L 
X indicates Course of x-ray therapy. 
L indicates Liver, iron, and high vitamin therapy. 
Table 1 and figure 1 summarize the changes in the blood picture from 
the original admission until the first hospitalization. Note here the fall 
in the leucocyte and erythrocyte counts. linfortunately blood counts 
were not obtained between January 2-l-, 1944 and :.\larch 29, 194-l-. \vhich 
makes full estimation of the changes during this period difficult. The 
leucocyte count fell rapidly from a level of 76,700 to 6,500 in a period 
of 12 weeks, and then gradually returned to a level ( 17,500) which clini-
cally is usually compatible with a leukemic life. These changes were 
undoubtedly clue to the irradiation therapy applied to the vegetative axis. 
During this interval a severe anemia developed, the incidence of which, 
ho\\Y';er, lagged about three weeks behind the fall in the leucocyte count. 
In vie\v of the fact that blood counts \vere not made during the early 
period of irradiation therapy, the question naturally arises as to how much 
of the change noted was a direct result of the irradiation therapy, and how 
much was clue to the invasion of the erythropoietic centers by lympho-
blastic cells. 
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Fig. 1-First Clinic Period 
T indicates blood transfusion 
X indicates x-ray therapy 
L indicates liver, iron, and vitamin therapy 
Table 2 and figure 2 summarize the blood and temperature picture 
during the first hospitalization. The sharp spiking temperature on admis-
sion is typical of an acute exacerbation of leukemia, although the leucocyte 
count at no time rose to the high levels seen at the time of the original 
admission: During this interval management of the anemia was one of 
the principle problems. At first tbis was controlled by daily transfusions 
and Reticulogen. Following study of the sternal puncture specimens, 
::small closes of x-ray to the ends of the long bones were used in an attempt 
to stimulate the erythropoietic centers. Following the initiation of this 
therapy it was found possible to increase the transfusion interval gradually 
to once weekly, and still maintain adequate erythrocyte and hemoglobin 
levels. At the same time a reticulocyte response was observed. A ques-
tion here presents itself. \Vas this change a direct result of the therapy, 
or merely a phase of remission in the anemic condition ? 
Of interest during this interval is the healing of the large pyoclermic 
lesion in the left mandibular and anterior axillary area in spite of a marked 
deficiency of granulocytes. As seen in table 2, the approximate ayerage 
granulocyte count was only 1200 cells per cu. mm., ranging betv\'een 0 
and 4000 cells per cu. mm. of blood. The normal range is between 5000 
and 7000 cells per cu. mm. \Ve must therefore give thought to the role 
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TABLE 2 
Erythro- Hemo- Reticula-
Date cytes in globin Leu co- Lympho- Granulo- Plate- cytes Treat-
millions per cent cytes cytes cytes lets per cent ment 
May 27 1.91 45.00 27,000 25,650 1350 40,000 0 .8 RPT 31 3 .02 58.77 28,000 28,000 0 RPT 
Jun. 1 3.03 52 .24 25,000 24,250 750 80,000 0.0 RPT 2 3.00 58.77 26,800 26,800 0 22,000 0.0 RPT 3 3 .84 65 .30 30,800 30,184 616 24,000 0.0 RPT 
4 4.21 78.36 51,000 50,490 510 20,000 0.0 RPT 6 4.50 85.00 33,000 32,670 330 9,000 0.0 RPT 
7 4 . 70 87.06 36,400 35,672 728 8,000 0 .0 R 8 3 .80 78 .36 26,300 25,248 1052 10,000 0.0 R T 
' 9 3.53 75.09 24,500 24,010 490 12,000 0.0 R 
10 3 . 17 71 .83 15,700 14,444 1099 15,000 0.0 R T 11 3.90 81.62 28,300 26,602 1699 13,000 0 .0 R 
12 5 .02 81.62 31,000 27,570 4340 8,000 0.0 R T 
13 4.60 71.83 28,000 26,320 1680 24,000 R 
14 4 .50 75 .09 29,000 26,680 2320 16,000 0.0 R 
15 4.63 75.00 31,200 30,264 930 16,000 0.0 R TX 
16 4.38 84.89 27,000 24,840 2160 28,000 0.2 R 
17 4.62 75.09 25,700 23,901 1399 16,000 0.5 R X 
18 3 . 75 84 .00 25,000 23,500 1500 16,000 0.1 R T 
19 3.82 78.30 24,000 22,320 1460 24,000 0.0 R 
20 4.39 75.09 22,500 20,700 1800 18,000 0.0 R X 
21 4.88 71.83 23,000 19,550 3450 20,000 0.2 R T 
22 4 .64 75 .09 22,400 20,832 1568 20,000 0.0 R X 
23 4.90 75.09 23,000 21,160 1840 16,000 0.2 R 
25 4.50 75.09 20,000 18,000 2000 9,000 0.0 R T 
26 4.04 78.36 19,000 17,000 1140 12,000 0 .0 R 
27 4.00 84.89 21,000 19,740 1260 23,000 0.0 R 
28 4.95 81.62 22,500 18,675 3825 12,000 0.0 R X 
29 4.87 75 .09 24,000 23,000 960 16,000 0.0 R 
30 4.32 78.36 23,500 20,680 2820 20,000 0.3 R T 
Jul. 1 4.20 81.00 15,000 13,350 1650 10,000 0.1 R 
2 4.00 78.30 23,000 20,240 2760 11,000 0.1 R 
3 4.80 78.36 25,000 24,250 750 12,000 0 . 1 R X 
4 4.29 78.30 12,550 11,875 625 15,000 0 .0 R T 
5 4.20 78.30 14,000 12,880 1120 36,000 0 .0 R 
7 4.09 75.09 25,600 23,552 2304 12,000 0.1 R 
8 .30 71.80 21,000 20,580 420 R T 
R indicates intramuscular injection of 2 cc. of Reticulogen. 
P indicates intramuscular injection of 10 cc. of Pentnucleotide 3 times a day, and the 
administration of 4 yellow bone marrow Glanules by mouth 3 times a day. 
T indicates transfu~tion of 500 cc. of whole blood. 
X indicates x-ray treatment. 
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TABLE 2 
Erythro- Hemo- Reticula-
Date cytes in globin Leu co- Lympho- Granulo- Plate- cytes Treat-
millions per cent cytes cytes cytes lets per cent ment 
May 27 1.91 45.00 27,000 25,650 1350 40,000 0 .8 RPT 31 3 .02 58.77 28,000 28,000 0 RPT 
Jun. 1 3.03 52 .24 25,000 24,250 750 80,000 0.0 RPT 2 3.00 58.77 26,800 26,800 0 22,000 0.0 RPT 3 3 .84 65 .30 30,800 30,184 616 24,000 0.0 RPT 
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22 4 .64 75 .09 22,400 20,832 1568 20,000 0.0 R X 
23 4.90 75.09 23,000 21,160 1840 16,000 0.2 R 
25 4.50 75.09 20,000 18,000 2000 9,000 0.0 R T 
26 4.04 78.36 19,000 17,000 1140 12,000 0 .0 R 
27 4.00 84.89 21,000 19,740 1260 23,000 0.0 R 
28 4.95 81.62 22,500 18,675 3825 12,000 0.0 R X 
29 4.87 75 .09 24,000 23,000 960 16,000 0.0 R 
30 4.32 78.36 23,500 20,680 2820 20,000 0.3 R T 
Jul. 1 4.20 81.00 15,000 13,350 1650 10,000 0.1 R 
2 4.00 78.30 23,000 20,240 2760 11,000 0.1 R 
3 4.80 78.36 25,000 24,250 750 12,000 0 . 1 R X 
4 4.29 78.30 12,550 11,875 625 15,000 0 .0 R T 
5 4.20 78.30 14,000 12,880 1120 36,000 0 .0 R 
7 4.09 75.09 25,600 23,552 2304 12,000 0.1 R 
8 .30 71.80 21,000 20,580 420 R T 
R indicates intramuscular injection of 2 cc. of Reticulogen. 
P indicates intramuscular injection of 10 cc. of Pentnucleotide 3 times a day, and the 
administration of 4 yellow bone marrow Glanules by mouth 3 times a day. 
T indicates transfu~tion of 500 cc. of whole blood. 
X indicates x-ray treatment. 
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of lymphocytes as the secondary line of defense, and in the production 
of antibodies. The reader might, in this connection, be interested in the 
experiments of Ehrich and Harris. 1 
The very low platelet count during the entire course of management 
is interesting in view of the absence of hemorrhagic states except for the 
terminal interstitial pulmonary hemorrhage observed at autopsy. 
The elevated basal metabolic rate of plus 16 per cent, and the rapid 
sedimentation (fig. 4), are characteristic findings in this disease. 
TABLE 3 
Erythro- Hemo- Reticulo-Date cytes in globin Leu co- Lympho- Granulo- Plate- cytes Treat-
millions per cent cytes cytes cytes lets per cent ment 
Jul. 14 3.52 78.4 16,500 15,505 990 25,000 0.4 X 21 3.75 78.4 21,750 20,710 1090 X 28 3.74 71.9 16,000 15,680 320 13,000 0.4 X Aug. 4 2.41 55.6 23,700 21,804 1896 17,000 0.4 X 11 2.28 52 .3 15,800 14,250 750 13,000 0.1 TX 
18 2.09 55.0 12,000 11,040 840 14,000 0.2 X 25 1. 98 42.5 18,750 18,562 187 8,000 0.0 TX 1 2.29 52.3 18,000 18,000 0 9,000 0.0 X 8 1. 74 43.8 24,850 23,855 993 12,000 0.0 X 
T indicates Transfusion of 500 cc. of whole blood. 
X indicates x-ray treatment. 
Table 3 represents the blood changes during the second period of out-
patient management. During this period· the patient was ambulatory until 
just prior to his readmission to the hospital. The leucocyte count remained 
approximately constant, but the erythrocyte count declined in spite of the 
continuance of x-ray therapy to the long bones. The fact that the reticulo-
cyte response remained relatively high suggests that perhaps there might 
have been some response in the erythropoietic centers. 
Figure 3 and table 4 follow the blood picture and temperature during 
the final hospitalization. On admission, the severe anemia and spiking 
teinperature are charac-teristic of an acute exacerbation of the leukemic 
state, followed by remission, and then another exacerbation during which 
the patient expired. During this stay in the hospital the problem of· 
management of the lesion on the right leg presented itself. It apparently 
originated from lymphatic blockage and glandular breakdown. This 
opinion was based on the characteristics of the drainage, and the severe 
edema of the extremity distal to the lesion. When the les.ion failed to 
respond to irradiat·ion therapy the decision to incise and drain was made 
1 Ehrich, W. E. and Harris, T. N.: The Site of Antibody Formation, Science 
101 :2611 :28 (Jan. 12) 19-tS. · 
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patient management. During this period· the patient was ambulatory until 
just prior to his readmission to the hospital. The leucocyte count remained 
approximately constant, but the erythrocyte count declined in spite of the 
continuance of x-ray therapy to the long bones. The fact that the reticulo-
cyte response remained relatively high suggests that perhaps there might 
have been some response in the erythropoietic centers. 
Figure 3 and table 4 follow the blood picture and temperature during 
the final hospitalization. On admission, the severe anemia and spiking 
teinperature are charac-teristic of an acute exacerbation of the leukemic 
state, followed by remission, and then another exacerbation during which 
the patient expired. During this stay in the hospital the problem of· 
management of the lesion on the right leg presented itself. It apparently 
originated from lymphatic blockage and glandular breakdown. This 
opinion was based on the characteristics of the drainage, and the severe 
edema of the extremity distal to the lesion. When the les.ion failed to 
respond to irradiat·ion therapy the decision to incise and drain was made 
1 Ehrich, W. E. and Harris, T. N.: The Site of Antibody Formation, Science 
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in spite of recognition of the fact that the chances of healing were light, 
and the danger of infection great. It was felt that further delay in 
establishing drainage would result in spontaneous breakdown, with even 
greater danger of infection. The patient was relieved of a great deal of 
pain foll?wing the surgical establishment of drainage. 
During this phase it is of interest to note the almost complete disap-
pearance of granulocytes, due, as was later confirmed at autopsy. to the 
replacement of the myeloblastic series of cells with lymphoblastic. 
The points discussed above seem to the writer to be those of greatest 
clinical interest and should be, so far as possible, integrated with the 
radiologic discussion and autopsy findings. 
TABLE 4 
Erythro- Hemo-
Date cytes in globin Leu co- Lympho- Granulo- Plate-
millions per cent cytes cytes cytes lets 
Sep. 12 1.81 18.00 29,400 28,518 882 
13 1.10 18.00 30,000 29,400 600 13,000 
14 2.12 23.60 28,000 26,880 1120 12,000 
16 2.25 23.29 31,000 30,690 310 12,000 
17 31,000 30,690 310 26,000 
18 2.42 36.35 48,850 47,824 960 12,000 
19 2.47 52.24 36,000 35,280 720 12,000 
20 2.08 43.00 25,700 24,415 1285 12,000 
21 1. 75 32.60 20,000 20,000 0 
22 2.75 39.18 24,000 24,000 0 40,000 
23 2.84 45.71 30,700 30,393 309 11,600 
24 3.50 52.00 32,200 31,878 322 12,000 
25 3.00 51.10 29,000 28,710 290 12,000 
26 3.71 65.30 32,500 31,850 650 12,000 
27 2.90 54.00 33,900 33,222 678 
28 3.07 55.46 30,000 29,700 300 
29 3.36 52.24 21,000 21,000 0 16,000 
30 3.85 55.90 24,300 24,057 243 
Oct. 1 3.26 62.00 22,000 21,560 440 
2 3.16 45.71 20,900 20,691 209 
3 3.47 52.24 25,000 25,000 0 16,000 
4 3 .00 58.70 . 40,000 40,000 0 
5 3 .00 51.50 46,900 46,900 0 
7 3.10 52.24 32,000 32,000 0 
8 3 .00 53.60 33,000 33,000 0 
9 3.40 58.17 37,000 36,260 98 
10 3.69 58.00 33,000 33,000 0 12,000 
13 3.20 65 .30 33,500 33,500 0 12,000 
R indicates intramuscular injection of 1 cc. of Reticulogen. 
T indicates Transfusion of 500 cc. of whole blood. 
X indicates x-ray treatment. 
Reticulo-
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Fig. 4-Erythrocytic Sedimentation Rate. 
Radiologic Aspects 
This patient was received for roentgen therapy for a clinically 
established lymphatic leukemia, March 13, 1944. At that time the blood 
count submitted showed Hb. of 71.9%, erythrocytes 4,360,000, leucocytes 
76,700, with a differential count of small lymphocytes 47%, large lympho-
cytes 49%, polymorephonuclear cells 4%. It was decided to attempt to 
control the patient's condition through the medium of paravertebral irradi-
ation and we proceeded at once with treatment directed to right and left 
paravertebral parts throughout the entire extent of the vegetative axis. 
The patient was treated on alternate days, two ports being treated at each 
visit, each portal receiving 156 r in air, utilizing the following fa~tors: 
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Radiologic Aspects 
This patient was received for roentgen therapy for a clinically 
established lymphatic leukemia, March 13, 1944. At that time the blood 
count submitted showed Hb. of 71.9%, erythrocytes 4,360,000, leucocytes 
76,700, with a differential count of small lymphocytes 47%, large lympho-
cytes 49%, polymorephonuclear cells 4%. It was decided to attempt to 
control the patient's condition through the medium of paravertebral irradi-
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paravertebral parts throughout the entire extent of the vegetative axis. 
The patient was treated on alternate days, two ports being treated at each 
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tension-208 kv., current-25 ma., distance-50 em., added filter-.5 cu. 
plus 1 al., h.v.l.-.95 cu., r.p.m.-39, port size-S x 20 and 10 x 18 em. 
Treatment was continued until each port received in total 624 r in air. 
The treatment cycle was concluded April 19th. 
The patient received no further irradiation until June 15, 1944, at 
which time at the instance of the clinician irradiation was employed for the 
purpose of exciting changes in the bone marrow from the standpoint of 
production of granulocytes. This treatment was administered under the 
high voltage tube in doses ranging from 19 r to 39 r in air directed to the 
proximal femora, sternum, proximal limits of the humeri and also to the 
dorsal and lumbar vertebrae. This treatment was spaced at three to five 
day intervals, with each portal receiving in total from 78 to 117 r. This 
series of treatments was completed September 29th. 
A review of all of the factors pertinent to this case establishes clearly 
and with definiteness the necessity for full and complete cooperation be-
tween the internist and the radiologist in the management of the blood 
dyscrasias and particularly in the case of the leukemic patient. Over-
treatment by roentgen therapy is to be guarded against and prevented. In 
this instance the rapid fall in the leucocytic count noted early in the treat-
ment period of the patient shows clearly the rapid changes which may 
transpire with the patient under radiation therapy. It has been our expe-
rience, however, that with the use of high voltage therapy directed to the 
paravertebral regions, that the fall in the total leucocytic count is more 
gradual and therefore better controlled than in the case of direct lymph 
node or splenic irradiation; also that control of the patient is better secured 
than when using whole body irradiation. It also seems that the intervals 
between exacerbations are longer and the general protraction of life is 
enhanced when irradiation of the vegetative axis is utilized. 
It is our custom to withold splenic and direct lymph node irradiation 
until necessary and as a last resort. 
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tension-208 kv., current-25 ma., distance-50 em., added filter-.5 cu. 
plus 1 al., h.v.l.-.95 cu., r.p.m.-39, port size-S x 20 and 10 x 18 em. 
Treatment was continued until each port received in total 624 r in air. 
The treatment cycle was concluded April 19th. 
The patient received no further irradiation until June 15, 1944, at 
which time at the instance of the clinician irradiation was employed for the 
purpose of exciting changes in the bone marrow from the standpoint of 
production of granulocytes. This treatment was administered under the 
high voltage tube in doses ranging from 19 r to 39 r in air directed to the 
proximal femora, sternum, proximal limits of the humeri and also to the 
dorsal and lumbar vertebrae. This treatment was spaced at three to five 
day intervals, with each portal receiving in total from 78 to 117 r. This 
series of treatments was completed September 29th. 
A review of all of the factors pertinent to this case establishes clearly 
and with definiteness the necessity for full and complete cooperation be-
tween the internist and the radiologist in the management of the blood 
dyscrasias and particularly in the case of the leukemic patient. Over-
treatment by roentgen therapy is to be guarded against and prevented. In 
this instance the rapid fall in the leucocytic count noted early in the treat-
ment period of the patient shows clearly the rapid changes which may 
transpire with the patient under radiation therapy. It has been our expe-
rience, however, that with the use of high voltage therapy directed to the 
paravertebral regions, that the fall in the total leucocytic count is more 
gradual and therefore better controlled than in the case of direct lymph 
node or splenic irradiation; also that control of the patient is better secured 
than when using whole body irradiation. It also seems that the intervals 
between exacerbations are longer and the general protraction of life is 
enhanced when irradiation of the vegetative axis is utilized. 
It is our custom to withold splenic and direct lymph node irradiation 
until necessary and as a last resort. 
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